¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Y44"¿¡ ´ëÇÑ Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • Y44
    Agents primarily affecting blood constituents
    ÀÏÂ÷ÀûÀ¸·Î Ç÷¾×¼ººÐ¿¡ ÀÛ¿ëÇÏ´Â ¾àÁ¦
  • Y44.3
    Anticoagulant antagonists, vitamin K and other coagulants
    Ç×ÀÀ°í¼º ´ëÇ×Á¦(±æÇ×Á¦), ºñŸ¹Î K ¹× ±âŸ ÀÀ°íÁ¦
  • Y44.2
    Anticoagulants
    Ç×ÀÀ°íÁ¦
  • Y44.4
    Antithrombotic drugs [platelet-aggregation inhibitors]
    Ç×Ç÷ÀüÁ¦[Ç÷¼ÒÆÇ ÀÀÁý ¾ïÁ¦Á¦]
  • Y44.0
    Iron preparations and other anti- hypochromic-anaemia preparations
    ö È­ÇÕ¹° ¹× ±âŸ Ç×ÀúÇ÷»ö¼Ò¼º ºóÇ÷ Á¦Á¦
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á